DelveInsight’s “Head and Neck Cancer (HNC) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Head and Neck Cancer market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Head and Neck Cancer market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Head and Neck Cancer (HNC): An Overview
Head and Neck Cancers usually begin in the squamous cells that line the moist mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). These squamous cell cancers are often called squamous cell carcinoma or Head and Neck Cancer. The symptoms of Head and Neck Cancers may include a lump or a sore that does not heal, a sore throat that does not go away, difficulty in swallowing, and a change or hoarseness in the voice. Symptoms may vary depending on the site of the cancer.
Alcohol and tobacco use are the two most important risk factors for Head and Neck Cancers, especially cancers of the oral cavity, oropharynx, hypopharynx, and larynx. At least 75% of Head and Neck Cancers are caused by tobacco and alcohol use.
Head and Neck Cancer (HNC) Market Key Facts
The Head and Neck Cancer market size in the 7MM was observed to be USD 2,801 million in 2021.
In 2021, the Head and Neck Cancer market size in the US was USD 1,831 million. As per DelveInsight, the Head and Neck Cancer market size in the United States will grow at a CAGR of 8.2% by 2032.
Among the EU-5 countries, Germany had the highest Head and Neck Cancer market size in 2021, i.e., USD 219 million. The lowest Head and Neck Cancer market size was estimated in Italy in 2021.
In 2021, the total Head and Neck Cancer incident cases in the 7MM countries were 158,000, and these cases are anticipated to increase during the study period.
- Among the European countries, Germany had the highest number of incident cases of Head and Neck Cancer in 2021, followed by France. On the other hand, Italy had the lowest incident cases of Head and Neck Cancer.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Head and Neck Cancer market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Head and Neck Cancer market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Head and Neck Cancer (HNC) Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
Head and Neck cancer (HNC) Epidemiology Segmentation –
Incident cases of Head and Neck Cancer
Gender-specific Incident Cases of Head and Neck Cancer
Age-specific incident Cases of Head and Neck Cancer
Gender-specific Incident Cases of Head and Neck Cancer
Site-specific incident Cases of Head and Neck Cancer
Stage-specific incident Cases of Head and Neck Cancer
Head and Neck Cancer (HNC) Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Head and Neck Cancer market or expected to get launched during the study period. The analysis covers the Head and Neck Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Head and Neck Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Head and Neck Cancer Market Will Evolve by 2032 @
Head and Neck Cancer (HNC) Therapeutics Analysis
The Head and Neck Cancer Therapeutics Market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and the expected launch of emerging therapies.
Some of the key companies in the Head and Neck cancer (HNC) Market include:
PDS Biotechnology Corporation
And many others
Head and Neck cancer (HNC) therapies covered in the report include:
And many more.
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More –
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Head and Neck Cancer Competitive Intelligence Analysis
4. Head and Neck Cancer Market Overview at a Glance
5. Head and Neck Cancer Disease Background and Overview
6. Head and Neck Cancer Patient Journey
7. Head and Neck Cancer Epidemiology and Patient Population (In the US, EU5, and Japan)
8. Head and Neck Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Head and Neck Cancer Unmet Needs
10. Key Endpoints of Head and Neck Cancer Treatment
11. Head and Neck Cancer Marketed Products
12. Head and Neck Cancer Emerging Drugs and Latest Therapeutic Advances
13. Head and Neck Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Head and Neck Cancer Market Outlook (In US, EU5, and Japan)
16. Head and Neck Cancer Access and Reimbursement Overview
17. KOL Views on the Head and Neck Cancer Market
18. Head and Neck Cancer Market Drivers
19. Head and Neck Cancer Market Barriers
21. DelveInsight Capabilities
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report:
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports By DelveInsight
“Meniere’s Disease Market” research report provides a detailed overview of the historical and forecasted epidemiology as well as the Meniere’s Disease Market size, share, and trends in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics market.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States